The present invention relates to photosensitive compositions containing polynorbornene (PNB) polymers and certain additives that are useful for forming microelectronic and/or optoelectronic devices and assemblies thereof, and more specifically to compositions encompassing PNBs and certain multifunctional crosslinking agents, and two or more phenolic compounds which are resistant to thermo-oxidative chain degradation and exhibit improved mechanical properties.

An adhesive composition is described comprising unpolymerized cyclic olefin, a ring opening metathesis polymerization (ROMP) catalyst or precatalyst thereof, and one or more adhesion promoter polymers. In one embodiment, the adhesion promoter is a polyolefin comprising maleic anhydride or silicon-containing moieties. In one embodiment, a combination of at least one polymeric polyisocyanate and at least one polyolefin comprising maleic anhydride or silicon-containing moieties provides a synergistic improvement. In another embodiment, a polymeric polyisocyanate adhesion promoter comprising oxygen atoms in the backbone has been found useful for bonding substrates such as polyamide, polyether ether ketone, or polyether imide. Also described are methods of bonding a substrate and articles, such as an electric battery cold plate assembly.

Provided is a ring-opened copolymer containing a structural unit derived from a norbornene compound represented by general formula (I) below, a structural unit derived from a monocyclic olefin, and a branched structural unit, wherein the content of the branched structural unit is 0.005 to 0.08 mol % in the total repeating structural units of the ring-opened copolymer:

##STR00001##

wherein R.sup.1 to R.sup.4 each independently represent a hydrogen atom, a C.sub.1-20 linear saturated hydrocarbon group, or a substituent containing a halogen atom, a silicon atom, an oxygen atom or a nitrogen atom, and m is 0 or 1.

Provided is a ring-opened copolymer containing a structural unit derived from a norbornene compound represented by general formula (I) below, a structural unit derived from a monocyclic olefin, and a branched structural unit, wherein the content of the branched structural unit is 0.005 to 0.08 mol % in the total repeating structural units of the ring-opened copolymer:

##STR00001##

wherein R.sup.1 to R.sup.4 each independently represent a hydrogen atom, a C.sub.1-20 linear saturated hydrocarbon group, or a substituent containing a halogen atom, a silicon atom, an oxygen atom or a nitrogen atom, and m is 0 or 1.

Free-standing non-fouling polymers and polymeric compositions, monomers and macromonomers for making the polymers and polymeric compositions, objects made from the polymers and polymeric compositions, and methods for making and using the polymers and polymeric compositions.

Free-standing non-fouling polymers and polymeric compositions, monomers and macromonomers for making the polymers and polymeric compositions, objects made from the polymers and polymeric compositions, and methods for making and using the polymers and polymeric compositions.

The present disclosure provides, in some aspects, macromonomers of Formula (I), and salts thereof; methods of preparing the macromonomers, and salts thereof; Brush prodrugs (polymers); methods of preparing the Brush prodrugs; compounds of Formula (II); conjugates of Formula (III), and salts thereof; pharmaceutical compositions comprising a Brush prodrug, or a conjugate or a salt thereof; kits comprising: a macromonomer or a salt thereof, a Brush prodrug, a compound, a conjugate or a salt thereof, or a pharmaceutical composition; methods of using the Brush prodrugs, or conjugates or salts thereof; and uses of the Brush prodrugs, and conjugates or salts thereof. These chemical entities may be useful in delivering pharmaceutical agents to a subject or cell.

The present disclosure provides, in some aspects, macromonomers of Formula (I), and salts thereof; methods of preparing the macromonomers, and salts thereof; Brush prodrugs (polymers); methods of preparing the Brush prodrugs; compounds of Formula (II); conjugates of Formula (III), and salts thereof; pharmaceutical compositions comprising a Brush prodrug, or a conjugate or a salt thereof; kits comprising: a macromonomer or a salt thereof, a Brush prodrug, a compound, a conjugate or a salt thereof, or a pharmaceutical composition; methods of using the Brush prodrugs, or conjugates or salts thereof; and uses of the Brush prodrugs, and conjugates or salts thereof. These chemical entities may be useful in delivering pharmaceutical agents to a subject or cell.

Provided is a hydrogenated product of a cyclic polymer including a cyclic chain that includes a repeating unit of a ring-opened cycloolefin.

A polymer composition contains, based on a total weight of the polymer composition: a) 40 wt. % to 99 wt. % of a polyalkenamer derived from at least one cycloalkene having 5 to 12 carbon atoms, and b) 1 wt% to 60 wt. % of graphene. The polyalkenamer has a trans-isomer content larger than 50)wt.° /0 based on a weight of the polyalkenamer. A moulded article can be produced from the polymer composition, which can be a board, a film, a bristle, or a foam. The moulded article can be used as a clothing element, sport element, sealing material, electrically conductive article, friction control element, transportation element, or structural element.